arrow
M

Marja-Liisa Sumelahti

tampere university
H指数:21
被引数:1,675

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans

中度至重度急性偏头痛发作:关于三叉神经痛药物和三叉神经痛药物-非甾体抗炎药组合在个体化治疗计划中应用的论文

2025-12-180
OAAI
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study

fremanezumab在1140名偏头痛患者中的长期真实世界有效性与安全性(至少6个月治疗):欧洲泛欧PEARL研究的第三次中期分析

2025-10-010
OA
Consensus recommendations on the role of nurses in headache care: A European e-Delphi study
2024-05-060
OA
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
2023-11-213
OA
Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families (vol 98, pg 743, 2018)
NEURON
IF15
2018-09-0152
OAAI
Common Variant Burden Contributes to the Familial Aggregation of Migraine in 1,589 Families
NEURON
IF15
2018-05-0120
OAAI
The contribution of CACNA1A, ATP1A2 and SCN1A mutations in hemiplegic migraine: A clinical and genetic study in Finnish migraine families
2018-02-2736
OAAI